Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against PomDoctor, Ltd. (NASDAQ: POM) and its officers, alleging violations of federal securities laws. The lawsuit claims that PomDoctor engaged in a fraudulent stock promotion scheme and that insiders facilitated a coordinated dumping of shares during a price inflation campaign. Investors who purchased PomDoctor securities between October 9, 2025, and December 11, 2025, are encouraged to join the case and have until April 6, 2026, to request appointment as lead plaintiff.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Bronstein, Gewirtz & Grossman LLC Urges PomDoctor, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against PomDoctor, Ltd. (NASDAQ: POM) and its officers, alleging violations of federal securities laws. The lawsuit claims that PomDoctor engaged in a fraudulent stock promotion scheme and that insiders facilitated a coordinated dumping of shares during a price inflation campaign. Investors who purchased PomDoctor securities between October 9, 2025, and December 11, 2025, are encouraged to join the case and have until April 6, 2026, to request appointment as lead plaintiff.